FDA Inspection
Novartis Pharmaceuticals CorporationFDA Inspection 1100101 - Novartis Pharmaceuticals Corporation - August 21, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on August 21, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2
Violation Codes4
21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.180(e)(2)21 CFR 211.192
Full citation text and observation details available on the Dashboard.